KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Long-Term Debt Repayments (2016 - 2022)

Medpace Holdings (MEDP) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $49.5 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Long-Term Debt Repayments changed N/A year-over-year to $49.5 million, compared with a TTM value of $49.5 million through Mar 2022, changed N/A, and an annual FY2019 reading of $80.4 million, up 4176.34% over the prior year.
  • Long-Term Debt Repayments was $49.5 million for Q1 2022 at Medpace Holdings, down from $56.4 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $56.4 million in Q2 2019 and bottomed at -$6.9 million in Q3 2018.
  • Average Long-Term Debt Repayments over 3 years is $18.8 million, with a median of $7.8 million recorded in 2018.
  • The sharpest move saw Long-Term Debt Repayments plummeted 321.82% in 2018, then soared 5221.51% in 2019.
  • Year by year, Long-Term Debt Repayments stood at $494000.0 in 2018, then skyrocketed by 11324.7% to $56.4 million in 2019, then dropped by 12.29% to $49.5 million in 2022.
  • Business Quant data shows Long-Term Debt Repayments for MEDP at $49.5 million in Q1 2022, $56.4 million in Q2 2019, and $24.0 million in Q1 2019.